Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment
Abstract Spastin is a microtubule (MT) severing enzyme that regulates several cell functions associated with MT dynamics. A reduction in spastin protein levels is responsible for approximately 40% of cases of Hereditary Spastic Paraplegia (HSP), a neurodegenerative disease. Currently, there is no cu...
Saved in:
Main Authors: | Francesca Sardina, Federica Polverino, Sonia Valentini, Claudia Carsetti, Elisabetta Falvo, Giada Tisci, Silvia Soddu, Fabiola Moretti, Alessandro Paiardini, Cinzia Rinaldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-025-02333-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
by: Abdullah Alatawi, et al.
Published: (2021-01-01) -
Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome
by: Federica Tiberio, et al.
Published: (2025-03-01) -
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion
by: Lucio Tremolizzo, et al.
Published: (2014-01-01) -
Primary liposarcoma of the uterus with MDM2 negative
by: Shufei Wei, et al.
Published: (2024-12-01) -
Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells
by: Rati Lama, et al.
Published: (2025-01-01)